Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0141950 Crystal (6S,9aS)-N-benzyl-8-({6-[3-(4-ethylpiperazin-1-yl)azetidin-1-yl]py- ...
The present invention provides a crystal of (6S,9aS)-N-benzyl-8-({6-[3-4-ethylpiperazin-1-yl)azetidin-1-yl]pyridin-2-- yl}...
2018/0141949 IMIDAZO[1,2-B][1,2,4]TRIAZINE DERIVATIVES AS ANTIPARASITIC AGENTS
A compound of Formula (I), or a salt thereof, ##STR00001## compositions comprising the compound, processes for its preparation and its use in therapy, for...
2018/0141948 NEW 5,8-DIMETHYL-9-PHENYL-5,8-DIHYDRO-6H-PYRAZOLO[3,4-H]QUINAZOLIN-2-YL)-(- 1H-PYRAZOL-3-YL)-AMINES AND...
The present invention encompasses compounds of formula (I) wherein the groups A, R and q are defined in claim 1, their use as inhibitors of IGF-1 R,...
2018/0141947 Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta
The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases...
2018/0141946 Imidazo-pyrimidone Compounds, and Preparation Method and Application Thereof
Compounds of formula (I), imidazopyrimidine ketones, as well as preparations and applications thereof. Compounds and pharmaceutically acceptable salts thereof...
2018/0141945 P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS
The present application provides novel compounds and methods for preparing and using these compounds. In one embodiment, the compounds are of the structure of...
2018/0141944 INHIBITOR COMPOUNDS
The present invention relates to compounds of formula I ##STR00001## wherein R.sub.1, R.sub.4, Ar, W, X and Z are all as defined herein. The compounds of the...
2018/0141943 Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
The specification generally relates to compounds of Formula (I): ##STR00001## and pharmaceutically acceptable salts thereof, where R.sup.1, R.sup.2, R.sup.3,...
2018/0141942 S1PR2 ANTAGONISTS AND USES THEREFOR
Methods and compositions are provided for the treatment of familial exudative vitreoretinopathy (FEVR) through the administration of a therapeutically...
2018/0141941 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
The present invention provides compounds of Formula I, ##STR00001## Pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising these...
2018/0141940 SALT FORM AND CRYSTAL FORM OF 1,2,5-THIADIAZOLIDIN-1,1-DIOXIDE, PREPARATION METHOD THEREOF AND INTERMEDIATE
The present invention discloses a salt form, crystal form and intermediate of the compound 1, and preparation method thereof. ##STR00001##
2018/0141939 SOLID FORMS OF A BET INHIBITOR
Forms of (2-cyclopropyl-6-(3,5-dimethylisoxazol-4-yl)-1H-benzo[d]imidazol- -4-yl)di(pyridin-2-yl)methanol (Compound I) were prepared and characterized in the...
2018/0141938 COMPOUNDS AND METHOD FOR TREATING AUTOIMMUNE DISEASES
Compounds and embodiments of a method for treating and/or preventing autoimmune diseases are disclosed. The method includes administering to a subject having...
2018/0141937 RETINOIC ACID RECEPTOR ANTAGONISTS AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS AND USES THEREOF
Compounds, compositions and methods are provided for selectively activating chaperone-mediated autophagy (CMA), protecting cells from oxidative stress,...
2018/0141936 CRYSTALLINE FORM OF THE COMPOUND (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]- ...
The present invention relates to a crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]- ...
2018/0141935 USE OF COMPOUNDS COMPRISING TWO OR MORE HYDROPHOBIC DOMAINS AND A HYDROPHILIC DOMAIN COMPRISING PEG MOIETIES...
The present invention relates to the use compounds comprising two or more hydrophobic domains and a hydrophilic domain comprising a polyethylene glycol (PEG)...
2018/0141934 MODULATORS OF CHEMOKINE RECEPTORS
Compounds are provided as chemokine inhibitors having the structure: ##STR00001##
2018/0141933 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
The present specification relates to a spiro structure compound and an organic light emitting device including the same.
2018/0141932 DIAMIDE MACROCYCLES AS FACTOR XIA INHIBITORS
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables...
2018/0141931 SUBSTITUTED PIPERIDINYL TETRAHYDROQUINOLINES
The present application relates to novel substituted piperidinyltetrahydroquinolines, to processes for their preparation, to their use for the treatment and/or...
2018/0141930 SUBSTITUTED PIPERIDINYL TETRAHYDROQUINOLINES
The present application relates to novel substituted piperidinyltetrahydroquinolines, to processes for their preparation, to their use for the treatment and/or...
2018/0141929 PROCESS FOR THE PREPARATION OF 3-(3-CHLORO-1H-PYRAZOL-1-YL)PYRIDINE
This disclosure relates to the field of preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine and intermediates therefrom. These intermediates are useful in the...
2018/0141928 PROCESS FOR PREPARING 3-[(4S)-8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-a][1,4]BENZODIAZE- ...
A process for preparing 3-[(S)-7-bromo-2-(2-oxo-propylamino)-5-pyridin-2-yl-3H-1,4,-benzodiazepin- -3-yl]propionic acid methyl ester at a high conversion rate...
2018/0141927 INHIBITORS OF KRAS G12C MUTANT PROTEINS
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): ##STR00001## or a...
2018/0141926 NEBIVOLOL SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF
The present invention relates to nebivolol synthesis method and intermediate compound thereof. Specifically, the present invention relates to a method for...
2018/0141925 FUNCTIONALISED BENZOPYRAN COMPOUNDS AND USE THEREOF
Benzopyran compounds, the preparation thereof, and their use in methods for treating cancer and reducing the incidence or risk of cancer recurrence. The cancer...
2018/0141924 A PROCESS FOR THE PREPARATION OF TERPINOLENE EPOXIDE
The present invention relates to a process for the preparation of terpinolene epoxide by epoxidation of terpinolene.
2018/0141923 SELECTIVE HDAC1,2 INHIBITORS
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders...
2018/0141922 BENZOXAZINE DERIVATIVES AND USE IN HAIR DYEING
The invention relates to the use of a compound of formula (I) below, addition salts thereof, optical isomers, geometrical isomers and tautomers thereof and/or...
2018/0141921 THERAPEUTIC COMPOUNDS
The invention provides compounds and compositions that are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer,...
2018/0141920 6-BROMO-3-HYDROXY-2-PYRAZINECARBOXAMIDE CRYSTAL AND METHOD FOR PRODUCING SAME
The purpose of the present invention is to provide a method for producing 6-bromo-3-hydroxy-2-pyrazinecarboxamide in which the content ratio of impurities is...
2018/0141919 DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
Compounds and methods for treating diseases mediated by a P2X.sub.3 and/or a P2X.sub.2/3 receptor antagonist, the methods comprising administering to a subject...
2018/0141918 METHOD FOR PREPARING AZOXYSTROBIN AND ITS INTERMEDIATES
The present invention discloses a method for preparing azoxystrobin intermediates represented by formulae (1) and (2), comprising: controlling a compound...
2018/0141917 PROCESS FOR PREPARING 4-AMINO-PYRIDAZINES
Provided herein is a process for preparing a pyridazine amine compound of formula V, and a process for preparing dichloropyridazine amine compounds of formula...
2018/0141916 NOVEL SMALL MOLECULE FIEL1 INHIBITOR IN INFLAMMATORY AND FIBROTIC LUNG INJURY
Novel compounds are disclosed along with methods of inhibiting the TGF.beta. pathway and methods of treating Idiopathic Pulmonary Fibrosis (IPF) using such...
2018/0141915 METHOD FOR PREPARING IMIDAZOLE DERIVATIVE AND INTERMEDIATE THEREOF AND CRYSTAL FORM
Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a...
2018/0141914 PROCESS FOR THE PREPARATION OF ENZALUTAMIDE
Disclosed is a process for the preparation of Enzalutamide comprising the reaction (Scheme 2), wherein R can be alkyl, aryl, aryl-alkyl or heterocyclyl. ...
2018/0141913 TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE
Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration...
2018/0141912 VERSATILE RAFT AGENT
The present invention provides A RAFT agent of formula (I) where R.sub.a is selected from Cl Br, I, F, CF.sub.3, CN, C0.sub.2R, CONR.sub.2, OMe, N0.sub.2; R is...
2018/0141911 Quinoline Derivatives for Diagnosis and Treatment of Alzheimer's Disease
A new class of quinoline compounds is useful for the detection and treatment of Alzheimer's disease and other neurodegenerative diseases such as amyloidoses...
2018/0141910 FUSED-BICYCLIC ARYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation...
2018/0141909 ROR GAMMA (RORY) MODULATORS
Novel compounds according to Formula I ##STR00001## Meta or para or a pharmaceutically acceptable salt thereof wherein: A.sub.11-A.sub.14 are N or CR.sub.11,...
2018/0141908 PROCESS FOR THE PREPARATION OF HALOSUBSTITUTED TRIFLUOROMETHYLPYRIDINES
The present invention provides a process for the preparation of halosubstituted-6-trifluoromethyl pyridine of Formula I ##STR00001## wherein X is a halogen
2018/0141907 USE OF TETRAHYDROPYRIDINES IN THE TREATMENT OF SODIUM CHANNEL RELATED DISEASE AND DISORDERS
The present invention provides a method of treating one or more sodium channel related diseases or disorders in an individual, including related symptoms. The...
2018/0141906 INDOLE AND AZAINDOLE DERIVATIVE HAVING AMPK-ACTIVATING ACTIVITY
A compound is represented by formula: ##STR00001## or its pharmaceutically acceptable salt, wherein Y is substituted or unsubstituted alkyl, alkenyl, alkynyl,...
2018/0141905 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
Inhibitors of HBV replication of Formula (ID) ##STR00001## including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, R.sup.a...
2018/0141904 SUBSTITUTED CYCLIC AMIDES AS HERBICIDES
Disclosed are compounds of Formula 1, including all stereoisomers, N oxides, and salts thereof, ##STR00001## wherein R.sup.1, R.sup.4, R.sup.5, R.sup.6, J,...
2018/0141902 NOVEL CANNABINOID RECEPTOR CB2 LIGAND 4-(AMINOMETHYL)-N,N-DIALKYLANILINES
Disclosed herein are novel cannabinoid receptor-2 (CB2) agonists and inverse agonists represented by Formula (I), and method of modulating the activity of CB2...
2018/0141901 METHOD FOR PREPARATION OF BIS(FLUOROSULFONYL)-IMIDE
The invention relates to a method for the preparation of bis(fluorosulfonyl)-imide and its derivatives at elevated temperature.
2018/0141900 METHOD FOR MAKING N-(FLUOROSULFONYL) DIMETHYLAMINE
Dimethylamine (Me.sub.2NH) is reacted with sulfuryl fluoride (SO.sub.2F.sub.2) to form at least a first phase comprising N-(fluoro sulfonyl) dimethylamine...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.